Comirnaty Injection, Suspension
Product Images NDC 0069-2528
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Comirnaty (NDC 0069-2528). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Comirnaty 02)
Logo (Comirnaty 02a)
Logo (Comirnaty 02b)
Principal Display Panel (Glass Prefilled Syringe Label 2025-2026 Formula)
Principal Display Panel (Glass Prefilled Syringe Carton 2025-2026 Formula)
Principal Display Panel (Glass Single-Dose Vial Label 2025-2026 Formula)
Principal Display Panel (Glass Single-Dose Vial Carton 2025-2026 Formula)
Principal Display Panel (Glass Prefilled Syringe Label 2026-2027 Formula)
Principal Display Panel (Glass Prefilled Syringe Carton 2026-2027 Formula)
Principal Display Panel (Glass Single-Dose Vial Label 2026-2027 Formula)
Principal Display Panel (Glass Single-Dose Vial Carton 2026-2027 Formula)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.